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Background and Purpose: The TRPV4 ion channels are Ca2+ permeable, non‐
selective cation channels that mediate large, but highly localized, Ca2+ signals in the
endothelium. The mechanisms that permit highly localized Ca2+ changes to evoke
cell‐wide activity are incompletely understood. Here, we tested the hypothesis that
TRPV4‐mediated Ca2+ influx activates Ca2+ release from internal Ca2+ stores to
generate widespread effects.
Experimental Approach: Ca2+ signals in large numbers (~100) of endothelial cells in
intact arteries were imaged and analysed separately.
Key Results: Responses to theTRPV4 channel agonist GSK1016790A were hetero-
geneous across the endothelium. In activated cells, Ca2+ responses comprised local-
ized Ca2+ changes leading to slow, persistent, global increases in Ca2+ followed by
large propagating Ca2+ waves that moved within and between cells. To examine the
mechanisms underlying each component, we developed methods to separate slow
persistent Ca2+ rise from the propagating Ca2+ waves in each cell. TRPV4‐mediated
Ca2+ entry was required for the slow persistent global rise and propagating Ca2+
signals. The propagating waves were inhibited by depleting internal Ca2+ stores,
inhibiting PLC or blocking IP3 receptors. Ca
2+ release from stores was tightly
controlled by TRPV4‐mediated Ca2+ influx and ceased when influx was terminated.
Furthermore, Ca2+ release from internal stores was essential for TRPV4‐mediated
control of vascular tone.
Conclusions and Implications: Ca2+ influx via TRPV4 channels is amplified by Ca2+‐
induced Ca2+ release acting at IP3 receptors to generate propagating Ca
2+ waves and
provide a large‐scale endothelial communication system. TRPV4‐mediated control of
vascular tone requires Ca2+ release from the internal store.
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1 | INTRODUCTION
The endothelium plays a critical role in the regulation of numerous
vascular processes such as maintaining vascular tone, regulating the
passage of macromolecules and oxygen to tissues, modulating
immune responses, initiating angiogenesis, and controlling vascular
remodelling. The control by the endothelium of each process is
mediated by the generation of various signalling molecules that
include NO, prostacyclin, von Willebrand factor, tissue plasminogen
activator, and endothelial‐derived hyperpolarizing and contracting
factors (Taylor et al., 2003; Whorton, Willis, Kent, & Young, 1984).
The generation of each of these signalling molecules is controlled
tightly by changes in the cytoplasmic Ca2+ concentration in the
endothelium. Central therefore to an understanding of endothelial
function is an appreciation of the control of intracellular Ca2+
concentrations.
There are two major sources of Ca2+ for the endothelium: the
extracellular space and the intracellular Ca2+ store. Ca2+ influx from
the extracellular space is mediated mainly by channels present on
the plasmalemmal membrane. In many cell types, such as smooth
muscle and cardiomyocytes, the influx pathways are well character-
ized, and voltage‐dependent Ca2+ channels are major contributors
(Catterall, 2011; Nelson, Patlak, Worley, & Standen, 1990). In endo-
thelial cells, however, understanding of the Ca2+ influx pathways is
incomplete (Nilius, Droogmans, & Wondergem, 2003). Several mem-
bers of the transient receptor potential (TRP) superfamily of cation
channels are present in endothelial cells (Hofmann, Schaefer, Schultz,
& Gudermann, 2002; Nilius, Droogmans, & Wondergem, 2003). Of
these, the TRPV4 channel has attracted substantial interest because
of the channels' relatively high Ca2+ permeability (Filosa, Yao, & Rath,
2013; Watanabe et al., 2002). TRPV4 channels are expressed widely in
endothelial cells (Mendoza et al., 2010; Sullivan, Francis, Pitts, Taylor,
& Earley, 2012; Watanabe et al., 2002). TRPV4 channels were initially
demonstrated to be activated by hypotonicity‐induced cell swelling
(Liedtke et al., 2000; Mizuno, Matsumoto, Imai, & Suzuki, 2003). Later
studies revealed that the channel is also activated by various other
stimuli including mechanical stimulation (Gao, Wu, & O'Neil, 2003;
Kohler et al., 2006; Liedtke, Tobin, Bargmann, & Friedman, 2003),
moderate heat, endogenous chemicals such as anandamide,
arachidonic acid, and its epoxyeicosatrienoic acid metabolites, as well
as by a number of exogenous chemical ligands (Nilius & Voets, 2013;
Vriens et al., 2004; Watanabe et al., 2003) or UVB (Moore et al.,
2013; Yin et al., 2008). In the endothelium, by regulating the cytoplas-
mic Ca2+ concentration, TRPV4 channels may contribute to the
response to arachidonic acid metabolites, physical forces, and agonists
(Bagher et al., 2012; Freichel et al., 2001; Hartmannsgruber et al.,
2007; Kohler et al., 2006; Marrelli, O'Neil, Brown, & Bryan, 2007;
Mendoza et al., 2010; Watanabe et al., 2002; Zhang et al., 2009;
Zhang, Papadopoulos, & Hamel, 2013).
While large in amplitude, the Ca2+ rise evoked by activation of
endothelial TRPV4 channels is reported to be highly localized and con-
fined to within a few micrometres of the channels (Sonkusare et al.,
2012; Sonkusare et al., 2014). These highly localized Ca2+ signals
evoke endothelial and smooth muscle hyperpolarization and vascular
relaxation (F. Gao & Wang, 2010; Kohler et al., 2006; Ma et al.,
2013; Sonkusare et al., 2012; D. X. Zhang et al., 2009). The highly
localized nature of the Ca2+ signal provides tight spatial control of
the cellular effectors activated, for example, Ca2+‐activated K+ chan-
nels (Gao & Wang, 2010; Ma et al., 2013; Sonkusare et al., 2012).
However, more widespread Ca2+ rises throughout the cytoplasm
have been implicated in the regulation of endothelial structure, main-
tenance of the normal orientation of endothelial cells, the control and
selectively of endothelial permeability, and the production of anti-
thrombotic factors. TRPV4 channels have been proposed to play a role
in each of these processes (Noren et al., 2016; Phuong et al., 2017;
Thodeti et al., 2009; Thoppil et al., 2016). The question arises as to
how activation of TRPV4 channels may lead to Ca2+‐dependent
events throughout the cytoplasm if the increase in Ca2+ concentration
arising from TRPV4 channel activity remains localized to within a few
microns of the channel.
The second major source of Ca2+ in endothelial cells is the internal
Ca2+ store. Ca2+ release from the internal store may occur via
ryanodine receptors (RyRs) or IP3 receptors (IP3Rs). While RyRs may
be expressed in endothelial cells (Moccia, Berra‐Romani, & Tanzi,
2012; Mumtaz, Burdyga, Borisova, Wray, & Burdyga, 2011; Rusko,
Wang, & Vanbreemen, 1995), the functional role of the channels in
the endothelium is not clear given that RyR activators such as caffeine
do not increase cytoplasmic Ca2+ in endothelial cells (Borisova, Wray,
Eisner, & Burdyga, 2009; Wilson et al., 2019; Wilson, Lee, &
McCarron, 2016). Ca2+ release from the internal store in endothelial
cells may be mediated mainly by IP3Rs (Mumtaz et al., 2011; Wilson
What is already known
• TRPV4 channels are key Ca2+ permeable channels that
control endothelial function.
• TRPV4 channels generate large but highly localized Ca2+
signals.
What this study adds
• Ca2+‐induced Ca2+ release from IP3‐sensitive internal
store amplifies local Ca2+ signals from TRPV4 channel
activity.
• Ca2+‐induced Ca2+ release at IP3 receptors mediates
control of vascular contractility by endothelial TRPV4
channels.
What is the clinical significance
• Endothelial TRPV4 channels are involved in several
disease conditions such as cancer progression and
hypertension.
• Endothelial TRPV4‐mediated Ca2+‐induced Ca2+ release
at IP3 receptors offers a new target for drug development.
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et al., 2019). Ca2+ release via IP3R occurs in response to physical
forces and circulating vasoactive substances and contributes to the
control of several vascular activities such as vasorelaxation, endothe-
lial permeability, and production of anti‐thrombotic factors (Sun,
Geyer, & Komarova, 2017).
IP3Rs are themselves regulated by Ca
2+, in addition to IP3. Ca
2+
released via IP3Rs may induce a positive feedback Ca
2+‐induced Ca2+
release process at neighbouring IP3Rs. Indeed, Ca
2+ signals at IP3Rs
begin as a localized Ca2+ blip at a single receptor (∼1 μm spread) which
expand by Ca2+‐induced Ca2+ release opening neighbouring IP3Rs
generating a Ca2+ puff (∼4 μm spread). Puffs may further propagate
via Ca2+‐induced Ca2+ release to form a transient global Ca2+ elevation
throughout the cell or a Ca2+ “wave” (Berridge, 1997; Bootman, Niggli,
Berridge, & Lipp, 1997). These waves may move through all or part of
the cell (Bootman, Berridge, & Lipp, 1997). In some conditions that are
not fully understood, IP3‐evoked Ca
2+ waves may also move between
cells to provide a signalling system capable of coordinating the activity
of many cells (Leybaert & Sanderson, 2012).
While Ca2+ influx and release are activated separately, they are not
independent: Ca2+ influx can trigger release, and release can trigger
influx (McCarron, Chalmers, Bradley, Macmillan, & Muir, 2006). In
cardiomyocytes, Ca2+ influx via voltage‐dependent Ca2+ channels
may activate RyRs to evoke a large rise in Ca2+, inducing cell contrac-
tion. In smooth muscle cells, TRPV4 channel activity may lead to Ca2+‐
induced Ca2+ release acting at RyRs (Earley, Heppner, Nelson, &
Brayden, 2005). In astrocytes, Ca2+‐induced Ca2+ release occurs in
response to Ca2+ influx via TRPV4 channels but at IP3Rs rather than
at RyRs. This process amplifies and propagates the Ca2+ signal arising
from TRPV4‐mediated Ca2+ influx (Dunn, Hill‐Eubanks, Liedtke, &
Nelson, 2013). TRPV4‐mediated Ca2+ influx may also lead to recruit-
ment of IP3Rs and Ca
2+‐induced Ca2+ release in murine‐derived
cultured neuronal cells (Shen et al., 2018). These observations raise
the possibility of TRPV4‐mediated Ca2+ influx being able to generate
a more global increase in intracellular Ca2+ via Ca2+‐induced Ca2+
release in endothelial cells.
To explore this possibility, we examined the role that the internal
store plays in regulating alterations in intracellular Ca2+ evoked by
activation of TRPV4 channels. Here, we report that the IP3‐sensitive
Ca2+ store is critical for theTRPV4‐evoked global Ca2+ rise in endothe-
lial cells in intact blood vessels. Ca2+ influx generates Ca2+‐induced
Ca2+ release at IP3Rs to evoke Ca
2+ waves in the vascular endothe-
lium. IP3R‐dependent Ca
2+ waves are required for the endothelium‐
dependent vascular smooth muscle cell relaxation in response to
activation of TRPV4 channels.
2 | METHODS
2.1 | Animals
All animal care and experimental procedures complied with the
relevant UK Home Office Regulations, (Schedule 1 of the Animals
[Scientific Procedures] Act 1986, UK) and were approved by the
University of Strathclyde Animal Welfare and Ethical Review Body.
Animal studies are reported in compliance with the ARRIVE guidelines
(Kilkenny et al., 2010) and with the recommendations made by the
British Journal of Pharmacology. The Strathclyde Biological Protection
Unit is a conventional unit which undertakes FELASA quarterly health
monitoring. Male Sprague–Dawley rats (10–12 week old; 250–300 g),
from an in‐house colony, were used for the study. Sprague–Dawley
rats are a widely used experimental model with a wealth of back-
ground information to aid interpretation of results. The animals were
housed three per cage, and the cage type was North Kent Plastic
model RC2F with nesting material “Sizzle Nest.” A 12:12 light dark
cycle was used with a temperature range of 19–23°C (set point
21°C) and humidity levels between 45% and 65%. Animals had free
access to fresh water and SDS diet RM1 (rodent maintenance). The
enrichment in the cages was aspen wood chew sticks and hanging
huts.
All experiments used first‐ or second‐order mesenteric arteries iso-
lated from rats killed by either CO2 or by injection with pentobarbital;
no differences in the results were observed with either method.
Controls and experimental treatments were carried out in the same
tissue, so blinding and randomization were not used.
2.2 | High‐resolution imaging of endothelial Ca2+
signalling
Arteries (diameter of 200–230 μm) were isolated from the mesen-
teric bed, cleaned, then cut and pinned flat en face (endothelial side
facing up) on a Sylgard block. The endothelium was then preferen-
tially loaded with Cal‐520/AM (5 μM; with 0.02% Pluronic F‐127)
in physiological saline solution (PSS) at 37°C for 30 min (Wilson,
Lee, & McCarron, 2016; Wilson, Saunter, Girkin, & McCarron,
2016). Following incubation, arteries were gently washed with PSS,
and the Sylgard blocks were placed face down on a custom flow
chamber. Arteries were then continuously perfused with PSS at
1.5 ml·min−1 using a syringe pump. Endothelial Ca2+ activity was
stimulated by swapping the PSS syringe for one containing ACh
(100 nM) or GSK1016790A (GSK, 20 nM). GSK1016790A is a selec-
tive TRPV4 channel agonist and evokes Ca2+ influx in wild type but
not TRPV4 channel knockout mice (Mannaa et al., 2018; Sonkusare
et al., 2012).
In experiments examining the effects of various pharmacological
agents on stimulated endothelial Ca2+ signalling, drugs were added
to the perfusate and remained thereafter. Images were acquired at
10 Hz using an inverted fluorescence microscope (Eclipse TE300,
Nikon, Tokyo, Japan) equipped with a 40× objective (S Fluor, Nikon,
Tokyo, Japan, NA = 1.3) and an electron‐multiplying charge‐coupled
device camera (iXon Life; Andor Technology Limited, Belfast, North-
ern Ireland, UK) or on an upright epi‐fluorescence microscope (FN‐1,
Nikon, Tokyo, Japan) equipped with a 60× objective (CFI Fluor,
Nikon, Tokyo, Japan, NA = 1.0). Cal520/AM was excited at
488 nm using a monochrometer (Polychome IV, TILL Photonics,
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Graefelfing, Germany) or an LED illumination system (PE‐300Ultra,
CoolLED, Andover, UK).
In some experiments, the endothelium was loaded with Cal‐520
(5 μM) and a membrane permeant, caged IP3 (5 μM), and the Ca
2+
response to local photolysis of caged IP3 examined. In these experi-
ments, the endothelium was imaged as above, and a xenon flash lamp
(Rapp Optoelecktronic, Germany) was used to uncage IP3 (Olson,
Chalmers, & McCarron, 2012; Olson, Sandison, Chalmers, &
McCarron, 2012; Wilson et al., 2019).
2.3 | Extraction and analysis of endothelial Ca2+
signals
Endothelial Ca2+ signals were extracted automatically from fluores-
cence recordings using custom written Python software (RRID:
SCR_001658; Lee et al., 2018; Wilson, Lee, & McCarron, 2016;
Wilson, Saunter, et al., 2016). In brief, cellular regions of interest
(ROIs) were first generated from average‐intensity projections of each
time series recording. Intensity projections were sharpened (un‐sharp
mask filter) and thresholded, generating ROIs that encompassed the
majority of each cell's area. To facilitate comparisons in paired exper-
iments, for example, where Ca2+ activity was recorded before and
after pharmacological inhibition, ROIs were aligned and tracked across
separate image acquisitions. Only cells that remained within the field
of view for all recordings were included.
Cellular Ca2+ signals were extracted by averaging fluorescence
intensity within each of the ROIs, for each frame of the image stack.
Raw fluorescence signals (F) were expressed as fractional changes in
fluorescence intensity (F/F0) by dividing each intensity value by the
average intensity of a 100‐frame period exhibiting the least
activity/noise (F0, red in Figure S1B). The F0 period was determined
automatically by calculating, in series, the derivative of the signal,
the rolling (100‐frame) SD of the derivative, and the rolling (100‐
frame) summation of the rolling SD. The minimum value of the rolling
summation indicates the centre of the portion of the signal with the
least activity/noise.
The Ca2+ response to activation of TRPV4 channels contained two
main components: a “slow” persistent Ca2+ elevation rise in the base-
line Ca2+ levels and fast intracellular Ca2+ waves. To determine the
underlying mechanisms, we isolated the two components from each
F/F0 trace. The slow persistent Ca
2+ elevation (baseline) component
of each signal was extracted by applying an asymmetric least squares
(ALS) smoothing function (Figure S1C–E; Eilers & Boelens, 2005).
Signalling metrics describing this slow persistent Ca2+ elevation (ampli-
tude; time of activation, 10–90% rise time) were then calculated from
a fitted sigmoidal curve (Figure S1C–E). Cells were considered to
exhibit a persistent Ca2+ elevation if the slow F/F0 component rose
by more than 10‐fold the SD of the baseline noise. The propagating
Ca2+ wave (fast) component of each signal was extracted by dividing
each F/F0 trace by the ALS‐smoothed signal. This procedure effec-
tively flattens the baseline and removes any slow drift from the signal
(Figure S1C–E). Peaks in each Ca2+ signal arising from the waves were
then detected automatically, using a zero‐crossing detector on deriva-
tive F/F0 traces (Lee et al., 2018; Wilson, Lee, & McCarron, 2016).
Various signal metrics (number of peaks, peak amplitudes, peak dura-
tions, 10–90% rise time, and 90–10% fall time) were extracted from
the corresponding ALS‐smoothed F/F0 trace. Cells were considered
to exhibit Ca2+ wave activity if the F/F0 component exhibited at least
one event with an amplitude more than 10‐fold the SD of the baseline
noise.
In some experiments, Ca2+ signals were calibrated using Ca2þ
h i
¼ KD F − FminFmax − F, where KD = 320 nM. Fmax was determined at the end
of the experiment by the addition of ionomycin (1 μM) and F min the
signal in the absence of light to the camera.
2.4 | Measurement of vascular reactivity
To assess the endothelium dependence of contractile and dilation
responses, vascular reactivity to various agonists were assessed in en
face artery preparations. This technique permits simultaneous visuali-
zation of the endothelium and assessment of functional responses
(contraction and dilation) and was used so that we could confirm the
removal of the endothelium as required.
Arteries of 200–230 μm diameter were loaded with Cal‐520/AM
as above, except that they were pinned to the bottom of a custom,
Sylgard‐coated flow chamber. This flow chamber was designed to
facilitate the perfusion of solutions (1.5 ml·min−1) when mounted on
an upright microscope (FN‐1, Nikon, Tokyo, Japan). Handling and pin-
ning of the arteries were restricted to the outermost corners, leaving
the central portion of the vessels with intact endothelium and able
to contract/dilate freely.
Following incubation, arteries were gently washed with PSS and
left to equilibrate for 30 min in PSS (continuously perfused
1.5 ml·min−1 using a syringe pump). Contraction was stimulated by
swapping the PSS for one containing phenylephrine. The concentra-
tion of phenylephrine was titrated to contract arteries to ~20% of
resting diameter. Relaxation was stimulated by changing the
phenylephrine‐containing syringe for one containing phenylephrine
(at the same concentration) and either ACh (100 nM),
GSK1016790A (GSK, 20 nM), or sodium nitroprusside (SNP,
100 μM). Contractile and dilator responses were assessed before
and after (paired) various treatments in the same artery, as described
in the text. After treatment, antagonists were continuously present
in the PSS. The removal of the endothelium was achieved by gentle
mechanical disruption with a human hair that was superglued onto a
pipette tip. Endothelium removal was confirmed by the absence of
endothelial cells stained with the Ca2+ indicator Cal‐520/AM. After
the removal of the endothelium, arteries were left to equilibrate
for 60 min.
Images were acquired at 10 or 5 Hz (consistent within each exper-
imental protocol) using an upright fluorescence microscope equipped
with a 16× objective lens (0.8 NA; Nikon, Tokyo, Japan) and large
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format (1,024 × 1,024; 13‐μm pixels) back‐illuminated electron‐
multiplying charge‐coupled device camera (iXon 888; Andor, Belfast,
UK) and stored for offline analysis. An edge‐detection algorithm
(Lawton et al., 2019) was used to track the width of arteries in image
recordings. The algorithm extracts an intensity profile along a scanline
orientated perpendicular to the longitudinal axis of the vessel.
Each intensity profile was smoothed using a 251‐point, fifth‐order
Savitzky–Golay filter, and the first‐order derivative calculated. The
edges of the artery correspond to the maxima and minima of the
first‐order derivative, which were identified and tracked using a
zero‐crossing detector. The width of the artery equates to the
unfolded circumference of the intact vessel and was converted to
the equivalent diameter. To control for variation in the resting diame-
ters, summary contractile response data are expressed as the percent-
age reduction from resting diameter,while relaxation responses are
expressed as the percentage increase in diameter compared to resting
diameter (Figure S2).
2.5 | Matching arterial tone across experimental
conditions
Following the removal of the endothelium, arteries were significantly
more sensitive to phenylephrine. The concentration of phenylephrine
was titrated to achieve a level of tone that was comparable to that
achieved in the presence of a functional endothelium (Figure S2A).
In the presence of cyclopiazonic acid (CPA), Phenylephrine‐induced
contractions were transient, and it was not possible to achieve a stable
contraction. Therefore, assessing the effect of store depletion on
TRPV4‐induced dilation was not feasible. Instead, vessels were
pretreated with GSK and CPA, and the magnitude of the transient
contraction induced by phenylephrine was assessed. Furthermore,
after depletion of Ca2+ stores using CPA, a significantly higher concen-
tration of phenylephrine was required to generate comparable levels
of vascular tone (Figure S2B).
2.6 | Pressure myography
Diameter measurements of pressurized arteries were performed using
the VasoTracker open source pressure myograph system (system
(RRID:SCR_017233; Lawton et al., 2019). Mesenteric arteries were
dissected free from surrounding tissue, cleaned of connective tissue,
and mounted on similar sized glass pipettes in a VasoTracker pressure
myograph chamber. Arteries were pressurized to 70 mmHg, checked
for leaks, and left to equilibrate for 30 min in pre‐warmed (37°C) circu-
lating PSS, with intraluminal flow (~100 μl·min−1) established by a
10 cmH2O pressure gradient.
Artery diameter was monitored using an sCMOS camera
(DCC1545M, Thorlabs, New Jersey, USA) and recorded by
VasoTracker acquisition software. Arteries were contracted using
phenylephrine (~500 nM) to ~80% of resting diameter, which was
added to the perfusion solution. All other drugs (e.g., ACh and
GSK) were applied intraluminally. Summary relaxation data are
expressed as the percentage increase in diameter compared to rest-
ing diameter.
2.7 | Materials
Cal‐520/AM was obtained from Abcam (Cambridge, MA, USA).
Caged‐IP3 (caged‐IP3 4,5‐dimethoxy‐2‐nitrobenzyl) was obtained from
Sichem (Germany). Pluronic F‐127 was obtained from Invitrogen
(Carlsbad, CA, USA). U73343 was obtained from Tocris (St Louis,
MO, USA). All other drugs and chemicals were obtained from Sigma
(St Louis, MO, USA). GSK, HC067047, CPA, U73122, U73343, 2‐
aminoethoxydiphenyl borate (2‐APB), and ionomycin were dissolved
in DMSO and diluted to working concentration in PSS such that the
total volume of DMSO was less than or equal to 0.1%. All other drug
stocks were dissolved in water. The PSS consisted of the following
(mM): 145 NaCl, 4.7 KCl, 2.0 MOPS, 1.2 NaH2PO4, 5.0 glucose, 0.02
EDTA, 1.17 MgCl2, and 2.0 CaCl2 (adjusted to pH 7.4 with NaOH).
In experiments using a Ca2+‐free PSS, Ca2+ was substituted with
Mg2+ on an equimolar basis, and EGTA (1 mM) was included. All
solutions were freshly prepared each day.
2.8 | Data and statistical analysis
The data and statistical analysis in this study comply with the recom-
mendations of the British Journal of Pharmacology on experimental
design and analysis in pharmacology The n vales shown are the num-
bers of biological replicates (number of animals). For each replicate, a
single field of endothelial cells (Ca2+ imaging experiments) or a single
artery segment (vascular reactivity studies) was studied. Summary data
are presented graphically as paired mean responses, or as the grand
mean ± SEM of n biological replicates. Two‐tailed, paired t test (for
paired observations), independent two‐sample t tests or repeated
measures one‐way ANOVA with multiple comparisons were used as
indicated in the text. All statistical analyses were performed using
GraphPad Prism version 6.0 (RRID:SCR_002798; GraphPad Software,
La Jolla, CA, USA). A P value of <.05 was considered statistically
significant.
2.9 | Nomenclature of targets and ligands
Key protein targets and ligands in this article are hyperlinked to
corresponding entries in http://www.guidetopharmacology.org, the
common portal for data from the IUPHAR/BPS Guide to PHARMA-
COLOGY (Harding et al., 2018), and are permanently archived in the
Concise Guide to PHARMACOLOGY 2017/18 (Alexander,
Christopoulos et al., 2017; Alexander, Fabbro et al., 2017; Alexander,
Peters et al., 2017; Alexander, Striessnig et al., 2017).
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3 | RESULTS
3.1 | Characteristics of ACh‐ and GSK‐evoked Ca2+
signals
To determine if activation of TRPV4 channels in endothelial cells
evoked Ca2+ release from the internal store, endothelial cells were
loaded with the fluorescent Ca2+ indicator Cal520/AM and activated
with ACh (100 nM) or the TRPV4 channel agonist GSK (20 nM).
Ca2+ activity was then visualized in the fields of ~100 endothelial
cells. Cellular responses were analysed individually (Figures 1
and S1).
Ca2+ responses evoked by ACh and GSK were clearly different
(Figure 1). ACh evoked a rapid elevation in intracellular Ca2+ which
was followed by asynchronous oscillations across the field of view
(Figure 1; Mumtaz et al., 2011). Activation of TRPV4 channels
resulted in heterogeneous Ca2+ responses (Figure 1c, Movie S1, and
Figure S3) that consisted of several distinct phases (Figures 1 and 2).
FIGURE 1 ACh and GSK1016790A stimulate different Ca2+ signalling patterns. (a, b) Ca2+ dynamics visualized in a single en face endothelial
preparation stimulated with ACh (a), and GSK1016790A (GSK, b). Panels show: (i) composite images illustrating endothelial Ca2+ activity over
the time course of the experiment, scale bars = 50 μm; (ii) whole‐cell Ca2+ traces (F/F0) for all cells shown in the corresponding panel in (i) ranked
and coloured according to the magnitude of the signal (dark blue, low; dark red, high); (iii) a representative Ca2+ trace from a single cell; (iv) a rolling
summation (30 s) of the number of Ca2+ events (peaks) across the‐field of‐view; and (v) a rastergram display of Ca2+ activity, where each dot
represents the occurrence of a peak in the Ca2+ response from each cell. (c) Representative images showing endothelial cells that were most
sensitive (first 25% of endothelial cells to respond) to application of either ACh (green) or GSK (red). On average, 32.6% of cells that responded to
one agonist also responded to the other (indicated by yellow in right most panel; n = 3). Scale bars = 20 μm
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The response to GSK was, initially, small localized Ca2+ spikes which
led to a slowly increasing global cytoplasmic Ca2+ concentration
(Figures 2b and S4). The GSK‐evoked, global Ca2+ elevation eventu-
ally plateaued, but the time taken to plateau was significantly longer
when compared to ACh (Figure 1; 55.9 ± 6.4 s for GSK; 16.7 ± 4.7 s
for ACh; n = 6). Finally, large propagating Ca2+ waves developed
(Figure 2b,c and Movies S1 and S2). These waves propagated within
and between cells at a constant velocity of ~5 to 15 μm·s−1 (Figure
2b,c, Movie S2, and Figure S5). GSK‐evoked intracellular Ca2+ waves
were significantly lower in frequency than those for ACh
(0.05 ± 0.01 Hz for GSK; 0.22 ± 0.03 Hz for ACh; n = 6).
These results suggest there are at least major two components of
the Ca2+ signal arising from activation of TRPV4 channels: (a) initial
local signals which lead to a slow global rise in Ca2+ and (b) large fast
propagating Ca2+ waves.
We next sought to examine the mechanisms that give rise to the
GSK‐evoked Ca2+ signals. We first confirmed the reproducibility of
GSK‐evoked responses (20 nM) in the same preparation so that a
FIGURE 2 Activation of TRPV4 channels stimulates local and propagating Ca2+ events. (a) Representative Ca2+ image (left), cell outlines (middle), and
ΔF/F0 maximum intensity projection (right) illustrating the endothelial Ca
2+ response to activation of TRPV4 channels with GSK1016790A (GSK; 20 nM).
The ΔF/F0 image shows an increase in Ca
2+ across the field of endothelial cells. (b) GSK stimulates local Ca2+ events and propagating Ca2+ waves. Panels
show: (i) Ca2+ traces illustrating the effect of GSK on whole‐cell Ca2+ levels from cells indicated by the coloured outlines in (a); (ii) line scans (kymographs)
showing GSK‐evoked local Ca2+ events (1) and propagating Ca2+ waves (2). Kymographs in (ii) correspond to the times indicated by dashed lines in (i) and
were generated from F/FΔt movies, where FΔt is the running (20 s) baseline. (c) Ca
2+ waves propagate across multiple cells. Panels show: (i) time series of
the active front (determined by sequential subtraction) of a multicellular Ca2+ wave that spreads across four endothelial cells; (ii, iii) polar coordinate
system (ii), example F/FΔt radial line scans (iii, 20° integration angle), and polar plot (iv) showing the angular dependence of propagation distance/velocity
for the depicted Ca2+ event. Data in (c) are shown in Movie S2. All scale bars = 20 μm
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paired experimental design could be used to examine the effects of
blockers. There was no significant difference in any of the Ca2+ signal
parameters measured (number of peaks, peak amplitudes, peak
durations, 10–90% rise time, and 90–10% fall time) on repeated
applications of GSK (Figure S3).
3.2 | Ca2+ influx via TRPV4 channels is required to
initiate endothelial Ca2+signals
To examine the mechanisms underlying each component of the GSK‐
evoked Ca2+ signal, we developed methods to extract the slow global
rise in Ca2+ and the propagating Ca2+ waves (fast) component from
raw Ca2+ signals in each cell (Figure S1).
To determine if each component is dependent on Ca2+ entry, we
first performed experiments using a Ca2+‐free PSS (Figure 3a,b). The
removal of extracellular Ca2+ significantly decreased the percentage
of cells exhibiting “slow” global Ca2+ elevations and “fast” propagating
waves in response to GSK (Figure 3c). The velocity of residual Ca2+
waves was similar to those occurring in the presence of external Ca2+
(Figure 3d; 10.0 ± 1.1 μm·s−1 for control; 8.8 ± 0.7 μm·s−1 for Ca2+‐
free; n = 5). However, removal of external Ca2+ significantly reduced
the amplitude (Figure 3e; 0.28 ± 0.11 ΔF/F0 for control; 0.02 ± 0.10
ΔF/F0 for Ca
2+‐free; n = 6) and the frequency of occurrence
(Figure 3f; 4.1 ± 0.6 peaks per cell for control; 1.7 ± 0.1 peaks per cell
for Ca2+‐free; n = 6) of these residual propagating Ca2+ waves.
These results suggest that Ca2+ influx across the plasma membrane
is essential for the slow global increase in Ca2+ and for the propagating
Ca2+ waves evoked by GSK.
To test whether or not the slow global Ca2+ rise and propagating
Ca2+ waves evoked by GSK arose from the activation of TRPV4 chan-
nels, we pre‐incubated endothelial cells with the non‐selective TRPV
channel antagonist, ruthenium red (RuR; 5 μm, 20 min; Figure 4a,b).
RuR significantly reduced the percentage of cells responding to GSK
with slow global Ca2+ elevations and propagating Ca2+ waves
(Figure 4c). Pretreatment with RuR reduced the amplitude (Figure 4e;
0.33 ± 0.06 ΔF/F0 for control; 0.07 ± 0.01 ΔF/F0 for RuR; n = 6) and
the frequency of occurrence (Figure 4f; 13.4 ± 3.3 peaks per cell for
FIGURE 3 The removal of extracellular Ca2+ abolishes GSK‐evoked Ca2+ signalling. (a) Composite images showing GSK1016790A (GSK)‐evoked
Ca2+ activity in a single field of native mesenteric artery endothelial cells before (left, control) and after (right, Ca2+‐free) the removal of external
Ca2+. Images show basal Cal‐520/AM fluorescence (grey) with Ca2+ activity overlaid (red). Scale bars = 50 μm. (b) GSK‐evoked (20 nM; grey box)
cellular Ca2+ signals (F/F0) in the presence (left) and absence (right) of extracellular Ca
2+. F/F0 signals (top) were decomposed into fast (middle) and
slow (bottom) components. (c) Summary bar chart showing the percentage of cells that exhibited propagating Ca2+ waves (fast) and slow global
Ca2+ elevations (slow). (d–f) Paired summary data showing the effect of external Ca2+ inhibition on Ca2+ wave propagation velocity (d), peak
amplitude (ΔF/F0, e), and the number of peaks per cell (f). The left plots in (e and f) are scatter plots showing the mean Ca
2+ event amplitude, or
oscillation frequency, within each cell visualized in the experiment shown in panels (a and b). Individual data points are coloured (from blue, low to
red, high) according to the density (i.e., occurrence) of particular values. *P < .05, significantly different as indicated; paired Student's t test (n = 6)
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control; 3.2 ± 0.1 peaks per cell for RuR; n = 6) of propagating Ca2+
waves but had no effect on the velocity of propagating waves
(Figure 4d; 11.8 ± 0.7 μm·s−1 for control; 11.6 ± 1.7 μm·s−1 for RuR;
n = 5). A similar reduction in GSK‐evoked Ca2+ signalling was observed
using the selective TRPV4 channel antagonist, HC067047 (HC067;
10 μM, 20 min; Figure 5a,b). HC067 reduced the percentage of cells
exhibiting slow, global elevations and the percentage exhibiting fast,
propagating Ca2+ waves (Figure 5c). HC067 reduced the amplitude
(Figure 5e; 0.29 ± 0.08 ΔF/F0 for control; 0.08 ± 0.02 ΔF/F0 for
HC067; n = 6) and the frequency (Figure 5f; 5.5 ± 0.8 peaks per cell
for control; 0.7 ± 0.2 peaks per cell for HC067; n = 6) of propagating
Ca2+ waves. The velocity of residual Ca2+ waves was unaffected by
HC067 (Figure 5d; 13.1 ± 0.8 μm·s−1 for control; 13.6 ± 0.7 μm·s−1 for
HC067; n = 5).
Together, these results suggest that Ca2+ influx via TRPV4 chan-
nels is required to induce both the slow global rise component and
the propagating Ca2+ waves induced by GSK.
3.3 | GSK‐induced Ca2+waves require a replete
internal Ca2+ store, IP3 synthesis, and IP3 receptor
activation
Having confirmed a role for TRPV4‐mediated Ca2+ influx in GSK‐
stimulated Ca2+ signals, we next investigated the contribution of the
internal Ca2+ store using the sarcoplasmic/endoplasmic reticulum
Ca2+‐ATPase (SERCA) inhibitor, CPA (Figure 6a,b). Depletion of the
internal store by CPA decreased the percentage of cells exhibiting
the slow global rise component of the GSK‐evoked Ca2+ signal and
the percentage of cells in which propagating Ca2+ waves occurred
(Figure 6c). CPA significantly inhibited the wave propagation speed
(Figure 6d; 8.6 ± 0.4 μm·s−1 for control; 3.6 ± 0.5 μm·s−1 for CPA;
n = 6), amplitude (Figure 6e; 0.48 ± 0.12 ΔF/F0 for control;
0.17 ± 0.04 ΔF/F0 for CPA; n = 6), and frequency (Figure 6f;
4.3 ± 0.4 peaks per cell for control; 1.5 ± 0.2 peaks per cell for CPA;
n = 6) of Ca2+ waves. The amplitude of the slow global Ca2+ rise
FIGURE 4 Inhibition of TRPV channels with ruthenium red inhibits propagating Ca2+ waves and slow global Ca2+ elevations evoked by
GSK1016790A. (a) Composite images showing GSK1016790A (GSK)‐evoked (20 nM) Ca2+ activity in the absence (left) and presence (right) of
the broad‐spectrum TRPV channel antagonist ruthenium red (RuR; 5 μM, 20 min) in the same native mesenteric artery endothelial cells. Images
show basal Cal‐520/AM fluorescence (grey) with Ca2+ activity overlaid (red). Scale bars = 50 μm. (b) Raw F/F0 (top), fast (middle), and slow
(bottom) components of the GSK‐evoked (20 nM; grey box) Ca2+ signal in the absence (left) and presence (right) of RuR. (c) Summary bar chart
illustrating the effect of RuR on the percentage of cells exhibiting propagating Ca2+ waves and slow global Ca2+ signal components. (d–f) Paired
summary data showing the effect of TRPV channel inhibition on Ca2+ wave propagation velocity (d), peak amplitude (ΔF/F0, e), and the number of
peaks per cell (f). The left plots in (e–f) are scatter plots showing the mean Ca2+ event amplitude, or oscillation frequency, within each cell
visualized in the experiment shown in panels (a and b). Individual data points are coloured (from blue, low to red, high) according to the density (i.e.,
occurrence) of particular values. *P < .05, significantly different as indicated; paired Student's t test (n = 6)
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initially appeared to be reduced by CPA (Figure 6b). However, this
apparent decrease appears to occur in large part because of the
increase in baseline Ca2+ evoked by CPA and the non‐linear relation-
ship between Ca2+ concentration and F/F0 value. When the signals
were calibrated (see Section 2), the mean Ca2+ concentration increase
evoked by GSK was 123 ± 75 nM, but after CPA, GSK evoked a Ca2+
rise of 93 ± 44 nM (n = 3), showing no significant effect of CPA. CPA
itself evoked an increase in Ca2+ concentration from a resting value of
176 ± 52 to 335 ± 58 nM (n = 3). The elevated Ca2+ may account for
the reduced number of cells activated by GSK (Watanabe et al., 2003).
These results suggest that the internal store is required for the propa-
gating Ca2+ waves.
To explore the role of Ca2+ release from the internal store, we
examined the contribution of IP3 using pharmacological inhibition of
phospholipase C (PLC; Figure 7a,b). The PLC inhibitor, U73122, signif-
icantly reduced the percentage of cells activated by GSK, both for the
fast propagating Ca2+ waves and for the slow persistent Ca2+ eleva-
tion (Figure 7c). Although the mean amplitude of propagating Ca2+
waves was not significantly different in the presence of U73122
(1.32 ± 0.25 ΔF/F0 for control; 0.67 ± 0.14 for U73122; n = 5), there
was a significant reduction in the propagation velocity
(10.2 ± 0.4 μm·s−1 for control; 5.5 ± 0.7 μm·s−1 for U73122; n = 5)
and frequency of those events (Figure 7d‐f).
U73343, the inactive analogue of the PLC inhibitor U73122, had
no effect on GSK‐induced Ca2+ signals (Figure S6). The percentage
of cells exhibiting slow and propagating Ca2+ wave components of
the GSK‐evoked signal were unaltered. Pretreatment with U73343
did not significantly alter the propagation velocity (9.4 ± 0.4 μm·s−1
for control; 7.7 ± 0.3 μm·s−1 for U73343; n = 5), amplitude
(1.34 ± 0.26 ΔF/F0 for control; 1.34 ± 0.14 for U73343; n = 5), nor
the frequency (3.5 ± 0.3 peaks/cell for control; 4.3 ± 0.6 peaks/cell
for U73343; n = 5) of propagating Ca2+ waves. Moreover, although
FIGURE 5 Inhibition of TRPV4 channels with HC067047 inhibits both propagating Ca2+ waves and slow global Ca2+ elevations evoked
by GSK1016790A. (a) Composite images showing GSK1016790A (GSK)‐evoked (20 nM) Ca2+ activity in the absence (left) and presence
(right) of the broad‐spectrum TRPV channel antagonist HC067047 (HC067; 10 μM, 20 min) in the same native mesenteric artery
endothelial cells. Images show basal Cal‐520/AM fluorescence (grey) with Ca2+ activity overlaid (red). Scale bars = 50 μm. (b) Raw F/F0
(top), fast (middle), and slow (bottom) components of the GSK‐evoked (grey box) Ca2+ signal in the absence (left) and presence (right) of
HC067. (c) Summary bar chart illustrating the effect of HC067 on the percentage of cells exhibiting propagating Ca2+ waves and slow global
Ca2+ signal components. (d–f) Paired summary data showing the effect of TRPV4 channel inhibition on Ca2+ wave propagation velocity (d),
peak amplitude (ΔF/F0, e), and the number of peaks per cell (f). The left plots in (e–f) are scatter plots showing the mean Ca
2+ event amplitude,
or oscillation frequency, within each cell visualized in the experiment shown in panels (a and b). Individual data points are coloured (from blue,
low to red, high) according to the density (i.e., occurrence) of particular values. *P < .05, significantly different as indicated; paired Student's t
test (n = 6)
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U73122 inhibits the internal store Ca2+ pump in colonic smooth mus-
cle cells (Macmillan & McCarron, 2010), the blocker did not reduce
IP3‐evoked Ca
2+ release in endothelial cells (Figure S7).
These results suggest that the GSK‐evoked slow global rise in Ca2+
and propagating Ca2+ waves each have contributions from PLC
activation.
To investigate any role of IP3‐sensitive Ca
2+ stores in propagating
Ca2+ waves induced by activation of TRPV4 channels, we examined
the effects of the IP3R antagonist, 2‐APB, on GSK‐evoked endothelial
Ca2+ signalling (Figure 8). 2‐APB significantly reduced the percentage
of cells exhibiting propagating Ca2+ waves but had no effect on the
percentage of cells exhibiting slow global elevations in Ca2+ in
response to GSK (Figure 8c). 2‐APB had no effect on the amplitude
(0.67 ± 0.09 ΔF/F0 for control; 0.60 ± 0.15 ΔF/F0 for 2‐APB; n = 6)
but significantly reduced propagation velocity (11.0 ± 0.8 μm·s−1 for
control; 2.0 ± 0.4 μm·s−1 for 2‐APB; n = 5) and frequency (3.1 ± 0.3
peaks per cell for control; 0.9 ± 0.3 peaks per cell for 2‐APB; n = 6)
of fast Ca2+ waves (Figure 8d–f).
To crosscheck the contribution of IP3Rs in the propagating Ca
2+
waves, we used caffeine—a potent inhibitor of IP3Rs (Ehrlich, Kaftan,
Bezprozvannaya, & Bezprozvanny, 1994; Parker & Ivorra, 1991; Saleem,
Tovey, Molinski, & Taylor, 2014). Caffeine, which does not evoke Ca2+
release in the endothelial cells under study and inhibits Ca2+ release
evoked by IP3 (Wilson et al., 2019), also blocked GSK‐evoked propagating
Ca2+ waves (Figure S8). Interestingly, caffeine also reduced the slow
global Ca2+ rise suggesting an effect of caffeine also on TRPV4 channels.
While Ca2+ influx via TRPV4 channels triggered large propagating
Ca2+ waves from the internal Ca2+ store, the release and influx did
not become an uncontrolled self‐regenerative process but remained
under the control of Ca2+ influx. When activation of TRPV4 channels
ceases, by washout of GSK, the propagating Ca2+ waves stop
(Figure S9 and Movie S3), and Ca2+ returned towards resting values.
FIGURE 6 Depletion of the internal Ca2+ store modifies the Ca2+ signal induced by activation of TRPV4 channels. (a) Composite images
showing GSK1016709A (GSK)‐evoked Ca2+ activity in the absence (left) and presence (right) of cyclopiazonic acid (CPA; 10 μM, 5 min) in the same
native mesenteric artery endothelial cells. Images show basal Cal‐520/AM fluorescence (grey) with Ca2+ activity overlaid (red). Scale bars = 50 μm.
(b) GSK‐evoked (20 nM; grey box) cellular Ca2+ signals in the absence and presence of CPA (left and right respectively). Original F/F0 traces (top)
were decomposed into fast (middle) and slow (bottom) components. CPA evoked a substantial increase in basal Ca2+ (see Section 3). In control and
in the presence of CPA, F/F0 was normalized to the Ca
2+ change before GSK so that the resting values in each case were 1. CPA caused a
substantial increase in resting Ca2+ (see text). (c) Summary bar chart illustrating the effect of CPA on the percentage of cells exhibiting propagating
Ca2+ waves and slow global Ca2+ elevations to GSK. (d–f) Paired summary data showing the effect of SERCA inhibition on Ca2+ wave propagation
velocity (d), peak amplitude (ΔF/F0, e), and the number of peaks per cell (f). The left plots in (e–f) are scatter plots showing the mean Ca
2+ event
amplitude, or oscillation frequency, within each cell visualized in the experiment shown in panels (a and b). Individual data points are coloured
(from blue, low to red, high) according to the density (i.e., occurrence) of particular values. *P < .05, significantly different as indicated; paired
Student's t test (n = 6)
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This result demonstrates that TRPV4 channels maintain control of
Ca2+ release from the internal Ca2+ store and the propagation of
Ca2+ waves both within and between cells.
3.4 | The functional effects of TRPV4 channels in
controlling vascular tone
Collectively, our results suggest that endothelial TRPV4‐mediated
Ca2+ influx activates Ca2+‐induced Ca2+ release at IP3Rs. To investi-
gate any physiological contribution of this process, we examined
vascular tone in mesenteric arteries (Figure 8) with and without a
functionally intact endothelial layer.
In intact, pressurized arteries, ACh and GSK each relaxed arteries
and reversed phenylephrine‐mediated contractions (Figure S10; n = 5).
Relaxations to GSK were reversed by the selective TRPV4 channel
antagonist, HC067. However, the dilations to AChwere preserved after
blockade of TRPV4 channels with HC067 (Figure S10; n = 5). These
results suggest that these channels do not contribute to ACh‐evoked
relaxations in rat mesenteric arteries (see also Hartmannsgruber
et al., 2007; Kohler et al., 2006; Wilson, Lee, & McCarron, 2016).
We next investigated the contribution of the internal Ca2+ store to
TRPV4‐mediated relaxation evoked by GSK. In en face preparations
(225 ± 4 μm resting diameter; n = 10), ACh and GSK each relaxed
phenylephrine‐constricted arteries back to pre‐constricted levels
(Figure 9 and Figure S2). In these same arteries, the removal of the
endothelium increased the sensitivity to phenylephrine and signifi-
cantly reduced relaxation to ACh (to 26 ± 7%; n = 5 vs. control with
endothelium). The residual ACh‐evoked response may have arisen
from the incomplete removal of the endothelium. The functional
removal of the endothelium also prevented GSK‐evoked relaxations.
Indeed, after the removal of the endothelium, GSK caused an increase
in tone (Figure 9e; n = 5). Endothelium removal did not prevent relax-
ation to the endothelium‐independent vasodilator SNP (Figure 9).
These results demonstrate that vascular relaxation to GSK occurs
via an endothelium‐dependent mechanism and not by acting directly
on the underlying smooth muscle.
FIGURE 7 PLC inhibition reduces the slow global Ca2+ rises and propagating Ca2+ waves of the GSK‐evoked Ca2+ response. (a) Composite
images illustrating GSK1016790A (GSK)‐evoked (20 nM) Ca2+ activity in the absence (left) and presence (right) of the PLC antagonist U73122
(2 μM, 10 min) in a single field of native mesenteric artery endothelial cells. Images show basal Cal‐520/AM fluorescence (grey) with Ca2+ activity
overlaid (red). Scale bars = 50 μm. (b) GSK‐evoked F/F0 (top) Ca
2+ signals, and corresponding fast (middle) and slow (bottom) signal components in
the absence (left) and presence (right) of U73122. (c) Summary data showing the effect of U73122 on the percentage of endothelial cells
exhibiting propagating Ca2+ waves (fast) and global Ca2+ elevations (slow). (d–f) Paired summary data showing the effect of PLC inhibition on Ca2+
wave propagation velocity (d), peak amplitude (ΔF/F0, e), and the number of peaks per cell (f). The left plots in (e–f) are scatter plots showing the
mean Ca2+ event amplitude, or oscillation frequency, within each cell visualized in the experiment shown in panels (a and b). Individual data points
are coloured (from blue, low to red, high) according to the density (i.e., occurrence) of particular values. *P < .05, significantly different as indicated;
paired Student's t test (n = 5)
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3.5 | Store dependence of the TRPV4 channel
response
We next examined the contribution of Ca2+‐induced Ca2+ release at IP3Rs
in TRVP4 mediated relaxation. To do this, we assessed the effect of GSK
on vascular reactivity before and after depletion of internal Ca2+ stores.
Depletion of the internal Ca2+ store using CPA (6 μM) prevents
stable contractions such that it was not possible to reliably assess
vasodilator responses in these arteries. Instead, we examined whether
pretreatment with GSK was capable of modulating PE‐evoked con-
traction (Figure 10). Pretreatment with GSK significantly attenuated
PE‐induced contractions (Figure 10a, c).
After Ca2+ store depletion using CPA, a higher concentration of
phenylephrine (3.6 ± 0.2 μM for control; 12.8 ± 2.2 μM for CPA;
n = 5) was required to achieve a level of contraction (20 ± 2%;
n = 5) equivalent to control conditions (Figure S2). After store
depletion with CPA, pretreatment with GSK no longer attenuated
phenylephrine‐induced contraction (4 ± 2% contraction for GSK;
27 ± 6% contraction for GSK + CPA; n = 5; P < .05). Rather, GSK
tended to enhance the contraction to phenylephrine (Figure 10b, c).
Together, these results demonstrate that depletion of internal Ca2+
stores reduces the inhibitory effect of GSK pretreatment on
phenylephrine‐induced contraction.
4 | DISCUSSION
TRPV4 channels are emerging as key plasmalemmal channels that
mediates Ca2+ influx and physiological functions in the endothelium
(Fiorio Pla et al., 2012; Gao & Wang, 2010; Gifford et al., 2014; Ma
et al., 2013; Sayed et al., 2010; Schierling et al., 2011; Sonkusare
et al., 2012; Thodeti et al., 2009; Troidl et al., 2009). We have shown
that the Ca2+ increase in endothelial cells, arising from Ca2+ entry via
TRPV4 channels, may be amplified by a Ca2+‐induced Ca2+ release‐like
FIGURE 8 Inhibiting IP3 receptors prevents propagating Ca
2+ waves but not slow global Ca2+ elevations induced by activation of TRPV4
channels. (a) Composite images showing Ca2+ activity evoked by GSK1016790A (GSK, 20 nM) in the absence (left) and presence (right) of the
IP3R antagonist, 2‐APB (500 μM, 10 min) in a single field of native mesenteric artery endothelial cells. Images show basal Cal‐520/AM
fluorescence (grey) with Ca2+ activity overlaid (red). Scale bars = 50 μm. (b) GSK‐evoked (grey box) cellular Ca2+ signals (F/F0; top) were
decomposed into fast (middle) and slow (bottom) components. (c) Summary data illustrating the percentage of cells exhibiting propagating Ca2+
waves and slow global Ca2+ increases. (d–f) Paired summary data showing the effect of IP3R inhibition on Ca
2+ wave propagation velocity (d),
peak amplitude (ΔF/F0, e), and the number of peaks per cell (f). The left plots in (e–f) are scatter plots showing the mean Ca
2+ event amplitude, or
oscillation frequency, within each cell visualized in the experiment shown in panels (a and b). Individual data points are coloured (from blue, low
to red, high) according to the density (i.e., occurrence) of particular values. *P < .05, significantly different as indicated; paired Student's t test
(n = 6)
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mechanism acting at IP3Rs to generate propagating Ca
2+ waves. When
IP3R‐mediated Ca
2+ release was inhibited, TRPV4‐induced increases in
intracellular [Ca2+] and TRPV4‐mediated control of vascular tone was
supressed. These results highlight the significance of endothelial
TRPV4‐mediated Ca2+‐induced Ca2+ release at IP3Rs in controlling
vascular contractility (Figure 11).
FIGURE 9 ACh and GSK1016790A both cause endothelium‐dependent vasodilation. (a and b) The vasodilator effect of ACh (a; 100 nM) and
GSK1016790A (b; GSK; 20 nM) on phenylephrine (PE)‐contracted arteries before (+ endothelium) and after the mechanical removal of the
endothelium (− endothelium). After the removal of the endothelium, sodium nitroprusside (SNP) was used to test endothelium‐independent
vasodilation. Panels show: (i) images of an en face artery, illustrating the vessel's responses to phenylephrine and either ACh or GSK (in the
continued presence of phenylephrine ); (ii) full time course of the experiments shown in the corresponding panel (i); (iii) Summary data
(mean ± SEM, n = 5) illustrating the effect of the endothelium removal on vasodilator responses to the indicated agonist. Relaxations are expressed
as % change from PE‐induced tone. A negative value indicates an enhancement of phenylephrine‐induced contraction. Coloured arrows in (ii)
indicate the time at which relaxation to each agonist was assessed. All scale bars = 100 μm. *P < .05, significantly different as indicated; repeated
measures one‐way ANOVA with multiple comparison
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In this study, we analysed individual TRPV4‐mediated Ca2+
responses in large numbers of endothelial cells in intact blood vessels.
Two components, a slow global increase and propagating Ca2+ waves,
contributed to the Ca2+ response to activation of TRPV4 channels.
The response to activation of TRPV4 channels was also heteroge-
neous among cells. Some cells were highly responsive, while other
cells responded weakly or not at all (see also Aird, 2012; Huang,
Chu, Chen, & Jen, 2000; Lee et al., 2018; Marie & Beny, 2002;
McCarron, Lee, & Wilson, 2017; McCarron et al., 2019; Wilson,
et al., 2016). We developed methods to automatically extract and sep-
arate the slow global increases and propagating Ca2+ waves occurring
in each endothelial cell. The changes in Ca2+ concentration triggered
by activation of TRPV4 channels consisted of different phases which
operated sequentially. First, rapid localized Ca2+ changes occurred
FIGURE 10 Ca2+ store depletion prevents TRPV4‐mediated opposition of vascular tone. (a and b) Effect of GSK1016790A (GSK, 20 nM) on
phenylephrine (PE)‐induced contraction in vessels with an intact internal Ca2+ store (a) or after depletion of the internal Ca2+ store (b) using
cyclopiazonic acid (CPA; 6 μm; bottom trace). Upper panels show images of en face arteries, pretreated with the indicated drug, before and after
exposure to phenylephrine. Corresponding diameter traces are shown in the lower panels. Data in (i) and (ii) show responses from the same artery.
Pretreatment with CPA and GSK consistently delayed the onset but increased the magnitude of the response to phenylephrine. The reason for the
delay is not clear. All scale bars = 100 μm. (c) Summary data (mean ± SEM, n = 5) showing the magnitude of phenylephrine‐induced contraction
(% resting diameter) under each of the conditions. Diameter measured at the times indicated by the red arrows on diameter traces. *P < .05,
significantly different as indicated; repeated measures one‐way ANOVA with multiple comparisons
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which led to a slow persistent global elevation in Ca2+ throughout the
cytoplasm. Then, large transient increases as a result of propagating
Ca2+ waves occurred. The large transient increases as a result of prop-
agating Ca2+ waves dominated the Ca2+ changes occurring in the
endothelium after a short time (~30 s).
Each of the Ca2+ changes occurring as a result of activation of TRPV4
channels was critically dependent on Ca2+ influx across the plasma mem-
brane. The Ca2+ changes were abolished after the removal of external
Ca2+ or by the inhibition of TRPV4 channels, with RuR or HC067047.
These results suggest that Ca2+ influx via TRPV4 channels generates the
persistent global Ca2+ rise. Inhibiting IP3‐mediated Ca
2+ release by deplet-
ing the internal Ca2+ store, or inhibiting IP3Rs, had little effect on the slow
persistent global elevation in Ca2+ but prevented the large transient
increases arising from propagating Ca2+ waves. This result suggests that
Ca2+ entry viaTRPV4 channels triggers activation of IP3Rs which amplifies
the initial Ca2+ rise and initiates regenerative release of Ca2+ in the form
of propagating waves. In support of the active nature of the Ca2+ waves,
the velocity of wave progression away from the release site was relatively
constant within and between cells (~5 to 15 μm·s−1). If diffusion alone
was responsible for wave progression, velocity and amplitude would
decline with distance from the release site. The mechanisms contributing
to TRPV4‐mediated activation of Ca2+ release and propagation may
include direct activation of IP3Rs (in a Ca
2+‐induced Ca2+ release like pro-
cess) or indirect Ca2+‐dependent activation of PLC. The partial inhibition
of the propagating Ca2+ waves by the PLC‐blocker, U73122, is consistent
with being a Ca2+‐induced Ca2+ release‐like process at IP3Rs. Basal PLC
activity has been reported for many PLC isoforms in biochemical experi-
ments (Running Deer et al., 1995; Willars et al., 1998) and in living cells
(Hardie et al., 2004; Willars et al., 1998) which may create a background
level of IP3 for Ca
2+‐induced Ca2+ release to occur.
Interestingly, blocking of PLC by U73122 also reduced the slow
global Ca2+ response (i.e., TRPV4‐mediated Ca2+ influx). Previous work
has shown that TRPV4 channels are inhibited by the phospholipid,
phosphatidylinositol 4,5‐bisphosphate (PIP2; Harraz, Longden,
Hill‐Eubanks, & Nelson, 2018). PLC‐mediated depletion of PIP2 results
in disinhibition of TRPV4 channels and increased Ca2+ influx (Harraz
et al., 2018). Thus, blocking of PLC by U73122 might be expected to
decrease TRPV4 channel activity.
To block IP3Rs, we used both 2‐APB and caffeine. 2‐APB is a
broad‐spectrum inhibitor that, although effective in blocking IP3Rs in
native endothelial cells, may inhibit Ca2+ entry pathways (see Peppiatt
et al., 2003; Trebak, Bird, McKay, & Putney, 2002; Voets et al., 2001;
Wilson, Lee, & McCarron, 2016). However, in the present experimen-
tal conditions, 2‐APB did not reduce the slow global Ca2+ rise evoked
by activation of TRPV4 channels suggesting that it is not inhibiting
influx in the present experiments. Caffeine, while often used as a
RyR activator, is a potent inhibitor of IP3Rs in the same concentration
range used to activate RyR (Ehrlich et al., 1994; Parker & Ivorra, 1991;
Saleem et al., 2014). Caffeine does not evoke Ca2+ release in endothe-
lial cells (Wilson, Saunter, Girkin, & McCarron, 2015) and inhibits Ca2+
release induced by photolysis of caged‐IP3 in the endothelium (Wilson
et al., 2019). That caffeine was effective in inhibiting propagating Ca2+
FIGURE 11 Model of TRPV4‐mediated control of vascular tone. Activation of TRPV4 channels (1) induces Ca2+ influx which results in a
persistent elevation in cytoplasmic Ca2+ concentration (2). Basal (Hardie, Gu, Martin, Sweeney, & Raghu, 2004; Running Deer, Hurley, &
Yarfitz, 1995; Willars, Nahorski, & Challiss, 1998) or Ca2+‐activated PLC (γ, δ, or β) activity decreases PIP2 and generates IP3 (3). Ca
2+ derived from
TRPV4 channel activity together with IP3 (McCarron, Chalmers, MacMillan, & Olson, 2010) act at IP3 receptors on the internal Ca
2+ store to induce
Ca2+ release (4). The released Ca2+ triggers propagating Ca2+ waves (5) by activating neighbouring IP3 receptors that ultimately result in
vasodilation (6). The entire process remains under the control of Ca2+ influx and terminates when TRPV4 channel activity ceases. This channel
activity is suppressed by PIP2 (7). ACh, via the M3 receptor, also activates PLC to generate IP3 and activate Ca
2+ release from the store. The
characteristics of M3‐ and TRPV4‐mediated Ca
2+ release differ significantly (see text)
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waves supports the conclusion that IP3Rs contribute to TRPV4‐
mediated Ca2+ responses.
RuR and HC067047 were each used to block TRPV4 channels.
RuR is an effective TRPV4 channel antagonist but also has effects
unrelated to this channnel. For example, RuR is an antagonist of chan-
nels such as the mitochondrial uniporter, the RyR, voltage‐dependent
Ca2+ channels, and other TRP channels. However, the effects of RuR
on these other channels are unlikely to explain the present findings.
RuR is not membrane permeant and will not have access to the
cytoplasm, so the effects on the mitochondrial uniporter or RyR are
unlikely to be of significance in the present study. While RuR may
have effects on voltage‐sensitive Ca2+ channels (Cibulsky & Sather,
1999), these channels do not appear to play a major role in endothelial
Ca2+ signalling. RuR may also inhibit other TRP channels, for example,
TRPC and TRPA. However, those channels are not activated by the
agonist used in the present study—GSK1016790A—suggesting that
channels other thanTRPV4 are unlikely contributors. The present find-
ings with RuR are also supported by the use of the more selective
TRPV4 channel antagonist HC067047 which also blocked the
response to GSK1016790A. Together, the findings point to TRPV4
channels as being the major target for RuR in the present study.
The increase in cytoplasmic Ca2+ concentration evoked by TRPV4‐
mediated Ca2+‐induced Ca2+ release at IP3Rs is large and regenerative,
as demonstrated by the long distance propagation. This process arises
(at least in part) because IP3Rs are activated by Ca
2+. TRPV4 channels
are also activated by Ca2+ (Strotmann, Schultz, & Plant, 2003). The
Ca2+‐dependent processes operating at IP3Rs and TRPV4 channels
are positive feedback mechanisms that should self‐reinforce and reach
a maximum in all‐or‐none fashion. However, TRPV4‐mediated Ca2+‐
induced Ca2+ release at IP3Rs does not become uncontrolled and,
while regenerative, remains tightly regulated by Ca2+ influx. The ques-
tion arises as to why maximum responses do not occur each time
TRPV4‐mediated influx begins. The answer may lie in IP3Rs and
TRPV4 channels being regulated to prevent uncontrolled influx and
release (Foskett, White, Cheung, & Mak, 2007; Nilius, Watanabe, &
Vriens, 2003). Two observations support this conclusion. First, when
TRPV4‐mediated Ca2+ influx ceases, the release of Ca2+ from IP3Rs
stops. Thus, Ca2+ release is tightly coupled to influx. Second, coordi-
nated activity of IP3Rs is required for propagating waves to occur.
The propagation of Ca2+ waves requires sequential opening and then
closing of IP3Rs. Thus, after activation, the IP3R must become refrac-
tory to ensure a directional propagation of the signal. The decline in
Ca2+ occurring at the back of the wave presumably follows from a
functional compartmentalization of the endoplasmic reticulum which
renders the site of IP3‐mediated Ca
2+ release refractory to the
phosphoinositide. The functional compartmentalization may arise
from a lowered local Ca2+ concentration in the lumen of the endoplas-
mic reticulum, or increased Ca2+ concentrations could deactivate the
receptors (Adkins & Taylor, 1999; McCarron, MacMillan, Bradley,
Chalmers, & Muir, 2004; Oancea & Meyer, 1996). These observations
highlight a system that is activated by Ca2+ influx, but is regulated to
prevent an uncontrolled positive feedback processes dominating the
TRPV4‐mediated increases in cytoplasmic Ca2+ concentrations.
As well as propagating at a constant velocity within cells, TRPV4‐
mediated Ca2+ waves could move seamlessly, at the same velocity,
across cell boundaries into neighbouring cells as intercellular Ca2+
waves (Movie S2). These waves were abolished by IP3R blockers or
removal of GSK. The mechanisms of intercellular wave propagation
are not entirely clear, but IP3Rs and (since the process stops when
GSK is removed) TRPV4 channel activities are both required for these
intercellular waves to occur.
In other tissues, intercellular Ca2+ waves may be a fundamental
mechanism for coordinating multicellular responses (Leybaert &
Sanderson, 2012). In the endothelium of small arteries of the mouse
cremaster muscle, rapidly spreading intercellular Ca2+ waves propa-
gate at a velocity of ∼116 μm·s−1 for distances up to ∼1 mm (Tallini
et al., 2007). These intercellular waves are associated with vasodilation
and are hypothesized to regulate blood flow to the parenchyma by
inducing upstream dilation of arterioles (Tallini et al., 2007). The inter-
cellular waves observed in the present study had a slower velocity (~5
to 15 μm·s−1) than those in mouse cremaster arterioles, suggesting a
different physiological control mechanism.
In previous studies, when endothelial IP3R‐mediated signalling was
eliminated by depletion of the internal Ca2+ store, activation of TRPV4
channels induced a large but highly localized (few square micrometres)
increase in Ca2+ concentrations (Sonkusare et al., 2012). These local-
ized Ca2+ signals were reported to activate endothelial Ca2+‐activated
K+ channels (Sonkusare et al., 2012) and lead to endothelial hyperpo-
larization and vasodilation (Sonkusare et al., 2012). However, activa-
tion of TRPV4 channels is known to also control the orientation of
endothelial cells, regulate endothelial permeability, and modulate the
production of antithrombotic factors, each of which may require a
more global [Ca2+] increase throughout the cytoplasm (Noren et al.,
2016; Phuong et al., 2017; Thodeti et al., 2009; Thoppil et al., 2016).
In the present study, IP3R‐mediated Ca
2+ release generated propagat-
ing Ca2+ waves and provided a mechanism by which TRPV4 channel
activity, in the presence of a functioning Ca2+ store, may generate
large rises in Ca2+ throughout the cytoplasm. These propagating
waves are critical for TRPV4‐mediated control of vascular tone. When
Ca2+ release from the internal store is inhibited, TRPV4‐mediated
endothelial control of tone is abolished (Figure 10). This result sug-
gests that control of vascular tone by TRPV4 channels is mediated
by Ca2+‐induced Ca2+ release via IP3Rs. It is tempting to also speculate
that the more general rise in Ca2+ throughout the cells, which occurs
as a result of the propagating IP3R mediated Ca
2+ waves, will facilitate
TRPV4‐mediated control of endothelial permeability and the produc-
tion of antithrombotic factors (Noren et al., 2016; Phuong et al.,
2017; Thodeti et al., 2009; Thoppil et al., 2016).
ACh evoked rapid asynchronous Ca2+ waves in neighbouring
endothelial cells. ACh‐evoked changes in intracellular Ca2+ concentra-
tion are linked closely to the IP3‐sensitive Ca
2+ store, but they do not
involve TRPV4 channels in rat arteries (Hartmannsgruber et al., 2007;
see also Kohler et al., 2006; Wilson, Lee, & McCarron, 2016;
Figure 10). While the response to the activation by ACh and activation
of TRPV4 channels each involved IP3, the Ca
2+ signals generated had
very different characteristics. ACh‐evoked Ca2+ increases did not
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appear to coordinate between cells. Activation of TRPV4 channels
evoked a slowly increasing baseline and large propagating Ca2+ waves.
Endothelial TRPV4 channels are involved in several cardiovascular
control mechanisms, including inhibiting vasoconstriction in small skel-
etal muscle arteries in response to increases in temperature (Gifford
et al., 2014), regulating myogenic tone (Bagher et al., 2012), remodel-
ling of the cytoskeleton and reorientation of the endothelial cells in
response to mechanical forces (Thodeti et al., 2009), collateral vessel
growth (Sayed et al., 2010; Schierling et al., 2011; Troidl et al., 2009),
and arachidonic acid‐induced endothelial cell migration required for
angiogenesis (Fiorio Pla et al., 2012). The present results show that
when the internal IP3 sensitive store is intact, TRPV4 channel activity
evokes IP3R signalling to generate Ca
2+ waves that propagate within
and between cells, and through the Ca2+ store, TRPV4 channels
modulate vascular contractility. The results demonstrate a link
between TRPV4 channel activity and Ca2+‐induced Ca2+ release at
IP3R in endothelial cells and offer a new target for drug development.
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